L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease.
Huot, Philippe
L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease. [electronic resource] - Neuropharmacology Oct 2012 - 829-36 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-7064
10.1016/j.neuropharm.2012.06.012 doi
Animals
Antiparkinson Agents--blood
Basal Ganglia--metabolism
Behavior, Animal--drug effects
Benserazide--administration & dosage
Biological Availability
Caudate Nucleus--metabolism
Chromatography, High Pressure Liquid
Dopamine Agents--blood
Drug Combinations
Dyskinesia, Drug-Induced--etiology
Female
Half-Life
Levodopa--administration & dosage
Macaca fascicularis
Metabolic Clearance Rate
Parkinsonian Disorders--cerebrospinal fluid
Severity of Illness Index
Spectrometry, Mass, Electrospray Ionization
Tandem Mass Spectrometry
Tissue Distribution
L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease. [electronic resource] - Neuropharmacology Oct 2012 - 829-36 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-7064
10.1016/j.neuropharm.2012.06.012 doi
Animals
Antiparkinson Agents--blood
Basal Ganglia--metabolism
Behavior, Animal--drug effects
Benserazide--administration & dosage
Biological Availability
Caudate Nucleus--metabolism
Chromatography, High Pressure Liquid
Dopamine Agents--blood
Drug Combinations
Dyskinesia, Drug-Induced--etiology
Female
Half-Life
Levodopa--administration & dosage
Macaca fascicularis
Metabolic Clearance Rate
Parkinsonian Disorders--cerebrospinal fluid
Severity of Illness Index
Spectrometry, Mass, Electrospray Ionization
Tandem Mass Spectrometry
Tissue Distribution